J Antimicrob Chemother. 2006 Nov;58(5):911-5. Epub 2006 Sep 6.

Use of neuraminidase inhibitors to combat pandemic influenza.

Source

Infectious Diseases Unit, Leicester Royal Infirmary, Leicester LE1 5WW, UK.

Abstract

Since the last influenza pandemic in 1968, neuraminidase (NA) inhibitors have been licensed for the treatment and prophylaxis of seasonal influenza. Continuing outbreaks of highly pathogenic avian influenza H5N1 since 2004 have focused attention on the timing of the next pandemic and preparedness plans. Although immunization is the principal means of influenza prophylaxis, a well-matched efficacious vaccine is unlikely to be widely available for several months following the emergence of the pandemic strain. NA inhibitors could be used to contain and eliminate an emerging pandemic virus at source. If unsuccessful, they could still play a crucial role in reducing the medical impact of pandemic influenza as it spreads through countries. Accordingly, many authorities are creating stockpiles of NA inhibitors. However, the use of stockpiled drugs for treatment or prophylaxis, the rapid delivery to newly diagnosed cases and unknown characteristics of an emergent pandemic strain pose significant challenges to determining optimal use of stockpiles.

PMID:: 16956904; [PubMed - indexed for MEDLINE]

Free full text

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

IndexCopernicus

Medical

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Review Neuraminidase inhibitors and their role in avian and pandemic influenza. [Antivir Ther. 2007]
Review Neuraminidase inhibitors and their role in avian and pandemic influenza.
Crusat M, de Jong MD. Antivir Ther. 2007; 12(4 Pt B):593-602.
Review [Neuraminidase inhibitors and risk of H5N1 influenza]. [Ann Pharm Fr. 2007]
Review [Neuraminidase inhibitors and risk of H5N1 influenza].
Gras-Masse H, Willand N. Ann Pharm Fr. 2007 Jan; 65(1):50-7.
Pandemic avian influenza. [Lancet Infect Dis. 2005]
Pandemic avian influenza.
Mermel LA. Lancet Infect Dis. 2005 Nov; 5(11):666-7.
Review [Neuraminidase inhibitors in prophylaxis and treatment of influenza]. [Pol Merkur Lekarski. 2008]
Review [Neuraminidase inhibitors in prophylaxis and treatment of influenza].
Nitsch-Osuch A, Brydak LB, Wardyn AK. Pol Merkur Lekarski. 2008 Jul; 25(145):67-73.
Antiviral management of seasonal and pandemic influenza. [J Infect Dis. 2006]
Antiviral management of seasonal and pandemic influenza.
Hayden FG, Pavia AT. J Infect Dis. 2006 Nov 1; 194 Suppl 2:S119-26.

See reviews... See all...

Cited by 3 PubMed Central articles

The anti-tumor agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), induces IFN-beta-mediated antiviral activity in vitro and in vivo. [J Leukoc Biol. 2011]
The anti-tumor agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), induces IFN-beta-mediated antiviral activity in vitro and in vivo.
Shirey KA, Nhu QM, Yim KC, Roberts ZJ, Teijaro JR, Farber DL, Blanco JC, Vogel SN. J Leukoc Biol. 2011 Mar; 89(3):351-7. Epub 2010 Nov 17.
Antiviral susceptibility of avian and swine influenza virus of the N1 neuraminidase subtype. [J Virol. 2010]
Antiviral susceptibility of avian and swine influenza virus of the N1 neuraminidase subtype.
Stoner TD, Krauss S, DuBois RM, Negovetich NJ, Stallknecht DE, Senne DA, Gramer MR, Swafford S, DeLiberto T, Govorkova EA, et al. J Virol. 2010 Oct; 84(19):9800-9. Epub 2010 Jul 21.
Antiviral resistance during pandemic influenza: implications for stockpiling and drug use. [BMC Infect Dis. 2009]
Antiviral resistance during pandemic influenza: implications for stockpiling and drug use.
Arino J, Bowman CS, Moghadas SM. BMC Infect Dis. 2009 Jan 22; 9:8. Epub 2009 Jan 22.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Use of neuraminidase inhibitors to combat pandemic influenza.
Use of neuraminidase inhibitors to combat pandemic influenza.
J Antimicrob Chemother. 2006 Nov ;58(5):911-5. Epub 2006 Sep 6 .

PubMed
Characterization of human colorectal mucosa, polyps, and cancers by means of com...
Characterization of human colorectal mucosa, polyps, and cancers by means of computerized morphonuclear image analyses.
Cancer. 1990 May 1 ;65(9):2047-54.

PubMed
Demonstration of cognitive decline in Parkinson's disease using the Cambridge Co...
Demonstration of cognitive decline in Parkinson's disease using the Cambridge Cognitive Assessment (Revised) (CAMCOG-R).
Int J Geriatr Psychiatry. 2006 Oct ;21(10):977-82.

PubMed
Functional architecture of basal ganglia circuits: neural substrates of parallel...
Functional architecture of basal ganglia circuits: neural substrates of parallel processing.
Trends Neurosci. 1990 Jul ;13(7):266-71.

PubMed
Antibiotic-resistant infections in primary care are symptomatic for longer and i...
Antibiotic-resistant infections in primary care are symptomatic for longer and increase workload: outcomes for patients with E. coli UTIs.
Br J Gen Pract. 2006 Sep ;56(530):686-92.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: